Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check5 days agoChange DetectedRecruitment for the study has ended. The record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check12 days agoChange DetectedThe UI now displays Revision: v3.5.5, replacing v3.5.4 on the page. This reflects a small platform update to the record history view.SummaryDifference0.0%

- Check19 days agoChange DetectedThe study title was corrected to 'A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder', and the history log was updated to reflect the latest version with added sections such as Results Posted, Baseline Characteristics, Participant Flow, Document Section, IPDSharing, Eligibility, and Study Identification.SummaryDifference0.7%

- Check35 days agoChange DetectedThe study record history now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor update to the page version, reflecting changes in the ClinicalTrials.gov interface or underlying platform.SummaryDifference0.0%

- Check42 days agoChange DetectedA new 'Results Submitted' status appears in the record, and the previous 'No Results Posted' entry has been removed. This indicates that the study's results have been submitted and are awaiting posting.SummaryDifference0.0%

- Check49 days agoChange DetectedThe history now shows Revision: v3.5.3 as the latest entry, replacing v3.5.2. This reflects a small site update captured in the record history.SummaryDifference0.0%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.